NMC Mandate Enrolment of Medical Colleges as ADR monitoring centers under PvPI
Aiming to uplift regulatory standards for the overall collection, analysis and monitoring of Adverse Drug Reactions (ADRs) from the Public, National Medical Commission (NMC) has directed all medical colleges, standalone PG Institutions to enrol themselves as Adverse Drug Reaction Monitoring Centers with the Indian Pharmacopoeia Commission (IPC) under the Pharmacovigilance Program of India (PvPI) at the earliest.
Indian Pharmacopoeia is functioning as the National Co-ordination Centre, Pharmacovigilance Programme of India to collect, analyse and monitor the adverse drug reactions from the Indian population to promote Patient Safety and Safeguard the health of patients by ensuring that the benefits of the use of medicines outweigh the risk associated with its use
The collected ADRs data is a significant source of evidence of recommendations of regulatory interventions regarding the safety of medicines to the Central Drugs Standard Control Organisation (CDSCO)
In order to achieve the above objective, IPC has so far enrolled 652 Adverse Drug Monitoring Centres (AMCs).
In the 22 nd Meeting of the Governing Body of India Pharmacopoeia Commission held on 14.10.2022 under the chairmanship of the Secretary (HFW) it has been decided that all Medical colleges/ hospitals under the National Medical Commission should also be enrolled as AMCs with IPC.
Accordingly, all Medical colleges/hospitals under the National Medical Commission are directed to get themselves enrolled with Indian Pharmacopoeia Commission (IPC) as AMCs at the earliest.
National conference on Strengthening Medical Product Safety Surveillance
IPC in association with Ruby Hall Clinic, Pune is organizing a national conference on “Strengthening Medical Product Safety Surveillance” on November 12, 2022 at Sheraton Grand Hotel, Bund Garden Road, Pune- 411001
Workshop on Key Role of In-Vitro Diagnostic Medical Device Stakeholders in Materiovigilance Programme of India
Indian Pharmacopoeia Commission is organising a Workshop on “Key Role of In-Vitro Diagnostic Medical Device Stakeholders in Materiovigilance Programme of India” on Friday, July 22, 2022 between 10 am to 4 pm at Indian Pharmacopoeia Commission (IPC), Ghaziabad, (U.P).
Total seats: 40, Registration will be accepted based on first come first serve basis.
Registration fee is Rs.2000 inclusive of GST. Last date for registration is July 20 2022. The objective of the workshop is to create awareness about the regulation and safety surveillance system of medical devices in India among in-vitro diagnostic medical device manufacturers, distributors, importers and researchers in order to promote the safety of in-vitro diagnostic medical devices.
Date : July 22, 2022 , Friday Time : 10 am to 4 pm Place : Indian Pharmacopoeia Commission, Ghaziabad
Workshop –Cum-Training program on Pharmacovigilance
Indian Pharmacopoeia Commission is organising a Workshop cum Training Programme on Pharmacovigilance for NABH Accredited Hospitals on Monday, July 11, 2022 between 9 am to 1 pm at Shekhar Hospital, Uttarpradesh
Total seats: 50, Registration will be accepted based on first come first serve basis.
Registration fee is Rs.1180 inclusive of GST. Last date for registration is July 6 2022.